HBAN
47
2
VNO
52
-2
HPE
61
-2
PCAR
48
2
OKE
67
2
INTU
58
-5
MHK
56
3
PCG
83
3
ILMN
42
-4
CNX
83
4
FE
56
4
KLAC
63
-5
SIG
64
3
NOC
45
2
FMC
40
-10
SRCL
44
-11
FFIV
67
-3
RL
73
-3
CNP
65
2
VRSK
54
16
HBAN
47
2
VNO
52
-2
HPE
61
-2
PCAR
48
2
OKE
67
2
INTU
58
-5
MHK
56
3
PCG
83
3
ILMN
42
-4
CNX
83
4
FE
56
4
KLAC
63
-5
SIG
64
3
NOC
45
2
FMC
40
-10
SRCL
44
-11
FFIV
67
-3
RL
73
-3
CNP
65
2
VRSK
54
16
Financhill
Back

Cellectis SA Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
43

CLLS
Cellectis SA

Last Price:
2.21
Seasonality Move:
12.21%
Sell
36

SRPT
Sarepta Therapeutics

Last Price:
124.65
Seasonality Move:
-1.39%
Sell
43
Cellectis SA (CLLS) is a Sell

Is Cellectis SA a Buy, Sell or Hold?

  • The current Cellectis SA [CLLS] share price is $2.18. The Score for CLLS is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • CLLS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
36
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $124.53. The Score for SRPT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CLLS Stock Price Chart

What is Cellectis SA's stock price today?

  • The Cellectis SA share price today is $2.18
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLLS is experiencing slight selling pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $124.53
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.

CLLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 45.02 Sell
Chaikin Money Flow: -1027 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.22 - 2.36) Sell
Bollinger Bands (100): (1.98 - 2.68) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.18 Sell
Relative Strength Index (14 RSI): 35.54 Sell
Chaikin Money Flow: -49995 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (124.27 - 135.95) Sell
Bollinger Bands (100): (123.89 - 147.49) Sell

CLLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.23 Sell
20-day SMA: 2.27 Sell
50-day SMA: 2.21 Sell
200-day SMA: 2.57 Sell
8-day EMA: 2.22 Sell
20-day EMA: 2.25 Sell
50-day EMA: 2.25 Sell
200-day EMA: 2.39 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 125.45 Sell
20-day SMA: 127.75 Sell
50-day SMA: 135.2 Sell
200-day SMA: 127.53 Sell
8-day EMA: 125.39 Sell
20-day EMA: 128.04 Sell
50-day EMA: 132.59 Sell
200-day EMA: 128.64 Sell

Cellectis SA Earnings Growth & CLLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.76 per share, and a decrease next year of $0.35 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.96 per share, an increase next quarter of $2.81 per share, an increase this year of $4.41 per share, and an increase next year of $9.14 per share.

Cellectis SA Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):